Transplant Rejection and Immunosuppressants Flashcards

1
Q

what kind of HSN (so what is causing) causes hyperacute transplant rejection; timeframe?

A
Type II (antibody mediated!!)--> preformed anti-donor Abs attack graft vessels = ischemia and necrosis
* w/in minutes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what type of HSN causes Acute transplant rejection; timeframe

A

Type IV–> cytotoxic T cells react against foreign MHC I

*occurs weeks later, usually within 3 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cause of chronic transplant rejection; timeframe

A

Months to years–> MHC I on donor tissues is perceived by host CTL as being a self- MHC I presenting foreign antigen when it isnt = obliterative vascular fibrosis and fibrosis of graft tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what two things mediate chronic transplant rejection

A

Abs AND T-cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what type of transplant rejection is irreversible? reversible?

A
  1. Chronic is irreversible

2. Acute is irreversible with immunosuppresants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What causes graft vs host dz

A

Grafted T cells proliferate in the host and start reacting against all tissues (since it recognizes everything in host as foreign) –> severe organ dysfunction

T-cells causing, so is a Type IV hsn rxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what two transplant can lead to GVH dz

A
  1. Bone marrow transplant
  2. Liver transplant

*both organs rich in lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 symptoms of GVH

A
  1. maculopapular rash (neck, shoulders, ears, palms)
  2. Hepatosplenomegaly
  3. hemolysis/ jaundice
  4. G.I. sx (N/V abdominal pain, diarrhea)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

binds to cyclophilin and inhibits calcineurin

A

Cyclosporine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AE of cyclosporine

A
  1. nephrotoxicity –> due to vasoconstriction of afferent and efferent arterioles in kidney; this also leads to HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

binds to FK-binding protein to inhibit calcineurin

A

Tacrolimus (FK-506)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AE of tacrolimus

A

like cyclosporine, can cause nephrotoxicity and HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what other two AEs do tacrolimus and cyclosporine share

A
  1. gingival hyperplasia

2. hirsutism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

function of calcinuerin, why is blocking it helpful

A

transcription factor for IL-2–> no IL-2 = impaired T-cell proliferation and differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

binds FKBP-12 and inhibits mTOR

A

Sirolimus (rapamycin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

prodrug for 6-mercaptopurine

A

Azathioprine

17
Q

interferes with metabolism and synthesis of nucleic acids

A

Azathioprine

18
Q

must be avoided when taking allopurinol

A

Azathioprine (6-mercapturine is metabolized by xanthine oxidase, so inhibiting with allopurinol is a dumb idea)

19
Q

AE of azathiprine

A

Bone marrow suppression–> esp when taking allopurinol at some time

20
Q

inhibits IMP-dehydrogenase–> preventing synthesis of guanine

A

Mycophenolate

21
Q

binds to CD25 (IL-2 receptor)

A

Daclizumab

22
Q

interferes with TNF-alpha

A

Thalidomide

23
Q

3 drugs used for lupus nephritis (2 are of label, so mainly know on-label one)

A
  1. Azathioprine
  2. Cyclosporine
  3. Mycophenolate
24
Q

TNF-alpha mabs (2) used mainly for seronegative spondyloarthropathies and sometime for RA

A
  1. inflixumab

2. adalibumab

25
Q

mAb against glycoprotein IIb/IIIa

A

Abcixumab–> used to prevent cardiac ishemia in unstable angina (prevents platelet interactions)

26
Q

mAb against HER2 used in HER2+ breast CA

A

Trastuzumab

27
Q

mAb against CD20, used for B-cell non-Hodgkins

A

Rituxumab

28
Q

mAb to IgE

A

Omalizumab